| The role of BTK inhibition in the treatment of chronic lymphocytic leukemia: a clinical view FP Tambaro, D De Novellis, WG Wierda Journal of Experimental Pharmacology, 923-935, 2021 | 23 | 2021 |
| Amyloidoma of the tongue: case report, surgical management, and review of the literature D Adamo, R Gasparro, G Marenzi, M Mascolo, M Cervasio, G Cerciello, ... Journal of Oral and Maxillofacial Surgery 78 (9), 1572-1582, 2020 | 21 | 2020 |
| Innovative anti-CD38 and anti-BCMA targeted therapies in multiple myeloma: mechanisms of action and resistance D De Novellis, R Fontana, V Giudice, B Serio, C Selleri International Journal of Molecular Sciences 24 (1), 645, 2022 | 15 | 2022 |
| Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience R Iula, D De Novellis, F Trastulli, R Della Pepa, R Fontana, A Carobene, ... Frontiers in Oncology 12, 1026251, 2022 | 13 | 2022 |
| The TKI era in chronic leukemias D De Novellis, F Cacace, V Caprioli, WG Wierda, KM Mahadeo, ... Pharmaceutics 13 (12), 2201, 2021 | 13 | 2021 |
| Serum free light-chain ratio at diagnosis is associated with early renal damage in multiple myeloma: A case series real-world study D De Novellis, R Fontana, A Carobene, B Serio, I Ferrara, MC Martorelli, ... Biomedicines 10 (7), 1657, 2022 | 9 | 2022 |
| Pneumatosis cystoides intestinalis, a rare case in a pediatric patient following allogeneic hematopoietic stem cell transplantation: CT findings and literature review D Baldari, P Pizzicato, FP Tambaro, D De Novellis, C Brillantino, ... Radiology Case Reports 16 (10), 3120-3124, 2021 | 7 | 2021 |
| High-risk acute myeloid leukemia: a pediatric prospective F Cacace, R Iula, D De Novellis, V Caprioli, MR D’amico, G De Simone, ... Biomedicines 10 (6), 1405, 2022 | 5 | 2022 |
| Safety of subcutaneous daratumumab in anti-CD38 monoclonal antibody-naive patients with plasma cell disorders: a multicenter real-life experience D De Novellis, R Fontana, S Palmieri, R Della Pepa, M Di Perna, G Cetani, ... Targeted Oncology 18 (6), 885-892, 2023 | 3 | 2023 |
| A frail hairy cell leukemia patient successfully treated with pegylated interferon-α-2A D De Novellis, V Giudice, V Ciccone, P Erra, A De Vita, F Picone, B Serio, ... Journal of Clinical Medicine 12 (1), 193, 2022 | 3 | 2022 |
| Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA. 1 Variant in Fully Vaccinated Hematological Patients D De Novellis, V Folliero, V Giudice, L Pezzullo, G Sanna, R Fontana, ... Clinical and Experimental Medicine 23 (8), 4943-4953, 2023 | 1 | 2023 |
| Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition V Giudice, B Serio, S Errichiello, I Ferrara, A Galdiero, A Bertolini, ... European Journal of Haematology 111 (5), 729-741, 2023 | 1 | 2023 |
| Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma V Giudice, D De Novellis, R Guariglia, R Fumo, G Ciancia, B Serio, ... Journal of Clinical Laboratory Analysis 36 (12), e24782, 2022 | 1 | 2022 |
| Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens D De Novellis, R Fontana, B Serio, E Vaccaro, R Guariglia, D Morini, ... Cancer Medicine 13 (14), e7402, 2024 | | 2024 |
| Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter … G Mele, D Derudas, C Conticello, G Barilà, M Gentile, S Rocco, S Palmieri, ... Annals of Hematology, 1-11, 2024 | | 2024 |
| Lenalidomide‐induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B D De Novellis, A Raimondo, B Serio, C Baldi, V Giudice, S Lembo, ... Photodermatology, Photoimmunology & Photomedicine 40 (3), e12965, 2024 | | 2024 |
| Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from … B Serio, G Storti, M D’Addona, L Santoro, C Frieri, D De Novellis, ... Hematology Reports 16 (2), 234-243, 2024 | | 2024 |
| Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies V Giudice, M Ianniello, D De Novellis, L Pezzullo, N Petrillo, B Serio, ... Clinical and Experimental Medicine 24 (1), 69, 2024 | | 2024 |
| Limited efficacy of 3+ 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients B Serio, F Grimaldi, L Ammirati, M Annunziata, G De Santis, A Perrotta, ... Cancer Reports 7 (4), e2044, 2024 | | 2024 |
| Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients D De Novellis, D Derudas, D Vincelli, R Fontana, R Della Pepa, ... European Journal of Haematology, 2024 | | 2024 |
